Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503
- PMID: 28274562
- PMCID: PMC5441224
- DOI: 10.1016/j.jtcvs.2016.12.045
Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503
Abstract
Objective: Cancer and Leukemia Group B 140503 is an ongoing, multicenter randomized trial assessing whether sublobar resection is equivalent to lobectomy for the treatment of stage I A non-small cell lung cancer (NSCLC) ≤2 cm in diameter. The objective of this report is to determine the reasons precluding intraoperative randomization.
Methods: From June 15, 2007, to March 22, 2013, 637 patients were preregistered to the trial. Three hundred eighty-nine were randomized successfully (61%), and 248 patients were not randomized (39%). We analyzed the reasons for nonrandomization among a subset of the nonrandomized patients (208) for whom additional data were available.
Results: Of these 208 patients, undiagnosed benign nodules (n =104, 16% of all registered patients) and understaging of NSCLC (n =45, 7% of all registered patients) were the dominant reasons precluding randomization. Granulomas represent one-quarter of the benign nodules. The understaged patients had unsuspected nodal metastases (n =28) or other more advanced NSCLC. The rate of randomization was significantly greater in those patients who had a preoperative biopsy (P <.001).
Conclusions: In a carefully monitored cohort of patients with suspected small NSCLC ≤2 cm, a substantial number are misdiagnosed (benign nodules) or understaged. These patients may not have benefited from a thoracic surgical procedure. Preoperative biopsy significantly increased the rate of correct diagnosis. Preoperative biopsy of small suspected NSCLC will reduce the number of nontherapeutic or unnecessary thoracic procedures. Accuracy in preoperative diagnosis is increasingly important as more such small nodules are discovered through lung cancer screening.
Keywords: biopsy; clinical trial; lung cancer; lung nodule; non–small cell lung cancer; sub-lobar resection; surgery; understaging.
Copyright © 2017 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Is tissue the issue?J Thorac Cardiovasc Surg. 2017 Jun;153(6):1598-1599. doi: 10.1016/j.jtcvs.2017.03.099. Epub 2017 Apr 2. J Thorac Cardiovasc Surg. 2017. PMID: 28526109 No abstract available.
Similar articles
-
Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.J Thorac Cardiovasc Surg. 2014 Feb;147(2):754-62; Discussion 762-4. doi: 10.1016/j.jtcvs.2013.09.065. Epub 2013 Nov 23. J Thorac Cardiovasc Surg. 2014. PMID: 24280722 Clinical Trial.
-
Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.AJR Am J Roentgenol. 2021 Oct;217(4):871-881. doi: 10.2214/AJR.21.25618. Epub 2021 May 12. AJR Am J Roentgenol. 2021. PMID: 33978462
-
Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.J Clin Oncol. 2016 Sep 10;34(26):3175-82. doi: 10.1200/JCO.2015.64.6729. Epub 2016 Jul 5. J Clin Oncol. 2016. PMID: 27382092
-
Is limited pulmonary resection equivalent to lobectomy for surgical management of stage I non-small-cell lung cancer?Interact Cardiovasc Thorac Surg. 2012 Jun;14(6):816-20. doi: 10.1093/icvts/ivs031. Epub 2012 Feb 27. Interact Cardiovasc Thorac Surg. 2012. PMID: 22374287 Free PMC article. Review.
-
Current readings: sublobar resection for non-small-cell lung cancer.Semin Thorac Cardiovasc Surg. 2013 Spring;25(1):22-9. doi: 10.1053/j.semtcvs.2013.01.005. Semin Thorac Cardiovasc Surg. 2013. PMID: 23800526 Review.
Cited by
-
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).Lancet Respir Med. 2018 Dec;6(12):915-924. doi: 10.1016/S2213-2600(18)30411-9. Epub 2018 Nov 12. Lancet Respir Med. 2018. PMID: 30442588 Free PMC article. Clinical Trial.
-
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083. N Engl J Med. 2023. PMID: 36780674 Free PMC article. Clinical Trial.
-
Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer.Thorac Cancer. 2018 Aug;9(8):1026-1031. doi: 10.1111/1759-7714.12782. Epub 2018 Jun 21. Thorac Cancer. 2018. PMID: 29927089 Free PMC article.
-
Knowing the Bad: Adverse Event-Informed, High-Risk, Early-Stage Non-Small Cell Lung Cancer Treatment Options.Ann Am Thorac Soc. 2022 Dec;19(12):1975-1976. doi: 10.1513/AnnalsATS.202209-756ED. Ann Am Thorac Soc. 2022. PMID: 36454168 Free PMC article. No abstract available.
-
Comparative Effectiveness of Lobectomy, Segmentectomy, and Wedge Resection for Pathological Stage I Non-small Cell Lung Cancer in Elderly Patients: A Population-Based Study.Front Surg. 2021 Apr 15;8:652770. doi: 10.3389/fsurg.2021.652770. eCollection 2021. Front Surg. 2021. PMID: 33937317 Free PMC article.
References
-
- Agresti A. An Introduction to Categorical Data Analysis. 2nd. New York: John Wiley & Sons; 2007.
-
- Stokes ME, Davis CS, Koch GG. Categorical Data Analysis Using SAS. 3rd. Cary, NC: SAS Institute Inc; 2012.
-
- Steel RGD, Torrie JH. Principles and Procedures of Statistics. 2nd. New York: McGraw-Hill; 1980.
-
- Wellek S. Testing Statistical Hypotheses of Equivalence. Boca Raton, FL: Chapman & Hall/CRC; 2003.
-
- Smith MA, Battafarano RF, Meyers BF, Zoole JB, Cooper JD, Patterson GA. Prevalence of benign disease in patients undergoing resection for suspected lung cancer. Ann Thorac Surge. 2006;81:1824–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical